Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Sulfoxides Stories

2013-02-13 10:23:09

In an analysis of the results of interventions to eradicate the bacterium Helicobacter pylori (a risk factor for gastric cancer) in seven diverse community populations in Latin America, researchers found that geographic site, demographic factors, adherence to initial therapy and infection recurrence may be as important as the choice of antibiotic regimen in H pylori eradication interventions, according to a study appearing in the February 13 issue of JAMA. "Gastric adenocarcinoma is the...

2013-02-11 12:23:05

BERKELEY HEIGHTS, N.J., Feb. 11, 2013 /PRNewswire/ -- MedAccess, an Access Group Company, graced the cover of the January issue of PM360 as the overall "grand tier" winner of the Pharma Choice Awards, netting a gold in the coveted branded print ad category. The Access Group was also awarded an additional gold and a silver. PM360, a leading health-marketing industry trade magazine, recognizes the best print and digital campaigns in the industry. All submissions are placed online, where...

2013-01-18 23:02:16

The law firm of d´Oliveira & Associates is working with some of the leading Prilosec lawyers in the country handling Prilosec cases and want the public to know that they offer a “No Win No Fee Promise” for Prilosec users who have suffered osteoporosis-like bone fractures in the wrist, hip, spine, etc. This means that you would pay no legal fee unless and until you receive a settlement or award of your Prilosec claim and/or Prilosec lawsuit. (PRWEB) January 18, 2013...

2013-01-10 12:24:41

WESTBROOK, Maine, Jan. 10, 2013 /PRNewswire/ -- Artel is launching the first in a new line of 100% DMSO-based Sample Solutions for use with the MVS® Multichannel Verification System. These will provide users with the ability to measure the accuracy and precision of volumes of DMSO dispensed into microwell plates. The first in the new line of DMSO solutions dramatically simplifies the volume verification process for users of sub-microliter liquid handling instruments, and will help them...

2013-01-07 05:00:08

Law Firm offers no win - no fee promise for clients injured from Nexium, which has been linked to severe side effects such as osteoporosis, bone deterioration and esophageal cancer. (PRWEB) January 06, 2013 During the week of December 6, 2012, more than 1,000 Nexium bone injury lawsuits were centralized into an MDL in the U.S. District Court for the Central District of California. (In re. Nexium (Esomerprazole) Products Liability Litigation, MDL Docket No. 2404) The plaintiffs in these...

2012-12-25 05:02:53

On December 6th, 2012, 39 lawsuits alleging Nexium caused bone fractures were consolidated in the Multidistrict Litigation MDL 2404 (Central District of California) by the U.S. Judicial Panel. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of alleged Nexium severe adverse events. [http://www.attorneyone.com/nexium-lawsuits/...

2012-12-18 16:25:01

BOCA RATON, Fla., Dec. 18, 2012 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Prescription Lansoprazole Delayed-Release Capsules. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Natco Pharma Limited, and will be available in both 15mg and 30mg strengths. Lansoprazole Delayed-Release Rx Capsules are AB rated to Prevacid®, a Proton Pump...

2012-12-13 12:32:39

It looks like your mother was on to something when she said, "Eat your vegetables!" A concentrated form of a compound called sulforaphane found in broccoli and other cruciferous vegetables has been shown to reduce the number of acute lymphoblastic leukemia cells in the lab setting, said researchers at Baylor College of Medicine. The findings appear in the current edition of PLOS ONE. "Acute lymphoblastic leukemia is a type of cancer of the white blood cells common in children," said Dr....

2012-12-11 08:27:39

WOODCLIFF LAKE, N.J., Dec. 11, 2012 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) determined that Eisai has met the FDA's Written Request requirements for pediatric exclusivity for ACIPHEX(® )(rabreprazole sodium). As a result, Eisai has now gained an additional 6 months of United States market exclusivity for ACIPHEX, which will expire on November 8, 2013. (Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO ) The granting of...

2012-11-30 08:24:39

WOODCLIFF LAKE, N.J., Nov. 30, 2012 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex® Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age. (Logo:...